Anixa Biosciences Inc — Director's Dealing 2024

May 2, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anixa Biosciences Inc (ANIX)
CIK: 0000715446
Period of Report: 2024-04-30

Reporting Person: Catelani Michael (President, COO, & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-04-30	Common Stock	A	1189	$2.52	Acquired	28961	Direct

Footnotes

F1: The reporting person purchased the shares of common stock reported hereunder pursuant to the Anixa Biosciences, Inc. Employee Stock Purchase Plan (the "Plan") which satisfies the requirements of Section 423 of the Internal Revenue Code. The reporting person's purchase of the shares of common stock is exempt from Section 16(b) under Rule 16b-3(c) and is exempt from the reporting requirements of Section 16 by virtue of Rule 16a-3(f)(1)(i)(B), however the reporting person has elected to voluntarily report the acquisition of the shares.

F2: In accordance with the Plan, the shares were purchased based on 85% of the closing price of Anixa Biosciences, Inc. common stock on April 30, 2024.